| NEW TRIAL DATA Learn more about the use of GLIVEC (imatinib) for your patients. Read More |
| Imatinib - Wikipedia, the free encyclopedia Imatinib (originally STI571) is a drug used to treat certain cancers. It is marketed by Novartis as Gleevec (USA) or Glivec as its mesylate salt, imatinib mesilate (INN). Read More |
| Glivec® (Imatinib): For Treatment Of Ph+ Chronic Myeloid Leukemia ... Read information about Glivec (imatinib) from Novartis Oncology, for treatment of Ph+ Chronic Myeloid Leukemia (CML), Ph+ ALL, MDS/MPD, Hypereosinophilic Syndrome ... Read More |
| Imatinib (Glivec®) - Cancer Information - Macmillan Cancer Support Get information about a drug called imatinib (Glivec®) which is used to treat some cancers Read More |
| CML-Info - Glivec Glivec New Therapeutic Approaches to Treating CML. The most exciting new therapeutic approach to the treatment of CML is the introduction of signal transduction ... Read More |
| Welcome to GLEEVEC.com | GLEEVEC®(imatinib mesylate) Learn about a treatment for adult patients with KIT+ GIST, Ph+ CML, or other rare diseases. Click here to view Important Safety Information for GLEEVEC. Read More |
| Novartis drug Glivec® shows significant overall survival benefit ... Novartis drug Glivec® shows significant overall survival benefit for patients with GIST after three years of adjuvant treatment vs. one year Read More |
| Survey Participation Request Read frequently asked questions about KIT+ GIST symptoms, treatment and efficacy of GLIVEC. Read More |
| European Medicines Agency - Find medicine - Glivec This is a summary of the European public assessment report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the studies ... Read More |
| Glivec - European Drugs Reference Encyclopedia Glivec, - European Drugs Reference Encyclopedia ... Summary for the public What is Glivec? Glivec is a medicine that contains the active substance imatinib. Read More |
